ELDN 4.36 (+3.32%)
US28617K1016• Biotechnology• Biotechnology
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. ELDN

Eledon Pharmaceuticals (ELDN) Stock Highlights

4.36 | +3.32%
2024-12-21 06:02:24
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The companys lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.

Statistics

Range Today
3.95 4.42
Volume Today 2.23M
Range 1 Year
1.43 5.54
Volume 1 Year 54.39M
Range 3 Year
1.07 5.54
Volume 3 Year 89.76M
Range 10 Year
1.07 2607.39
Volume 10 Year 130.29M

Highlights

Market Capitalization 288.54M (small)
Floating Shares 30.73M
Current Price 4.36
Price To Earnings 11.09
Earnings Per Share 0.45
Payout Ratio 0%

Performance

Latest +3.32%
1 Month +11.79%
3 Months +73.71%
6 Months +63.3%
1 Year +183.12%
3 Years -8.02%
5 Years -52.78%
10 Years -99.82%

Benchmarks

Market Capitalization

301 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

18 / 368

Free Cashflow

153 / 352

Performance 5 years

173 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.